| Income Statement | 2025-09-30 | 2025-03-31 | 2024-09-30 | |
|---|---|---|---|---|
| Total other income, net | 7,321 | 7,752 | 7,890 | |
| Net loss and comprehensive loss | -43,808 | -34,452 | -20,405 | |
| Net loss attributable to common stockholders | - | - | -20,405 | |
| Earnings per share, basic, total | -0.57 | -0.45 | -0.3 | |
| Earnings per share, diluted, total | -0.57 | -0.45 | -0.3 | |
| Weighted average number of shares outstanding, basic, total | 76,729,726 | 76,187,621 | 67,143,744 | |
| Weighted average number of shares outstanding, diluted, total | 76,729,726 | 76,187,621 | 67,143,744 | |
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON)